10% OffFirst Order? Use code
🔬 General ResearchPublished: August 19, 2026

MOTS-c: Mitochondrial-Encoded Peptide Regulation of Metabolic Homeostasis and AMPK Activation

“MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded in the 12S rRNA gene that functions as a systemic endocrine messenger, promoting skeletal muscle GLUT4 glucose uptake, activating AMPK via folate-cycle modulation, and driving nuclear retrograde stress adaptation.”

Peptide vial product illustration

Legal & Laboratory Compliance Notice

FOR IN-VITRO LABORATORY RESEARCH ONLY: This scientific publication is provided strictly for academic and biochemical reference by certified researchers. Materials and compounds referenced are NOT for human consumption, veterinary use, drug manufacture, or direct clinical administration. Statements have not been evaluated by Health Canada or the FDA.

Scientific Research Overview

Abstract & Executive Summary

Mitochondria were historically regarded solely as the energetic powerhouses of eukaryotic cells. However, the identification of MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) demonstrated that the 16,569-base-pair human mitochondrial genome encodes bioactive signaling peptides, known as Mitochondrial-Derived Peptides (MDPs).

Encoded by a short open reading frame (sORF) within the mitochondrial 12S ribosomal RNA locus, MOTS-c is translated in the cytoplasm and circulates systemically in human plasma. It functions as a classic peptide hormone, targeting skeletal muscle, liver, and adipose tissue to regulate energy homeostasis, enhance insulin-independent glucose clearance, and prevent diet-induced obesity.

+----------------------------------------------------------------------------------------------------+
|                                      MOTS-c MECHANISTIC CASCADE                                    |
+------------------------------------+----------------------------------+-----------------------------+
| Folate Cycle Interception          | AMPK Phosphorylation (Thr172)    | Nuclear Retrograde Action   |
| - Inhibits 5-MTHF synthesis        | - ACC inhibition (↑ Beta-Ox)     | - Translocates on stress    |
| - Causes de novo ZMP accumulation  | - GLUT4 plasma membrane insertion| - Binds NRF2 / ARE loci     |
| - Mimics AICAR energy depletion    | - Increases muscle glucose uptake| - Upregulates heat shock ptn|
+------------------------------------+----------------------------------+-----------------------------+

Chemical Structure & Sequence Architecture

  • Peptide Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
  • Single Letter Code: MRWQEMGYIFYPRKLR
  • Molecular Formula: C101H152N28O22S2
  • Molecular Weight: 2174.62 g/mol
  • CAS Registry Number: 1627580-64-6
  • Isoelectric Point (pI): ~10.8 (strongly basic due to three Arginine residues and one Lysine)
  • The "Exercise Mimetic" Concept

    In peer-reviewed animal trials published in Cell Metabolism and Nature Communications, MOTS-c administration demonstrated remarkable physiological overlap with physical endurance training:

  • Endurance Capacity: Aged mice treated with MOTS-c displayed substantial increases in treadmill running distance and grip strength.
  • Insulin-Independent Glucose Disposal: MOTS-c completely restored glucose tolerance in high-fat diet (HFD) induced insulin-resistant models without stimulating pancreatic insulin secretion.
  • Prevention of Sarcopenia: Promoted myogenic differentiation and suppressed muscle atrophy genes (Atrogin-1, MuRF1).
  • Mechanism of Action

    MOTS-c operates through a unique intracellular metabolic pathway distinct from classical peptide hormones:

    1. Folate-Methionine Cycle Inhibition & AICAR Generation

    MOTS-c targets the one-carbon folate-methionine metabolic pathway:

  • Inhibits 5-methyltetrahydrofolate (5-MTHF) production and downregulates methionine cycle flux.
  • This purine metabolic shift leads to the accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (ZMP / AICAR), an intermediate in the de novo purine synthesis pathway.
  • ZMP acts as an endogenous AMP mimetic, directly binding to the regulatory gamma-subunit of AMPK.
  • 2. AMPK Activation & Lipid Oxidation Reprogramming

    Elevated intracellular ZMP leads to the allosteric activation and phosphorylation of AMPK at Thr172 by upstream kinase LKB1:

  • Activated AMPK directly phosphorylates and inactivates Acetyl-CoA Carboxylase (ACC).
  • Inactivation of ACC decreases malonyl-CoA levels, relieving the allosteric inhibition of Carnitine Palmitoyltransferase-1 (CPT-1).
  • Fatty acyl-CoA enters the mitochondrial matrix freely, significantly accelerating beta-oxidation and reducing intramyocellular lipid accumulation.
  • 3. GLUT4 Translocation in Skeletal Muscle

    In skeletal myotubes, activated AMPK stimulates the phosphorylation of AS160 (Akt Substrate of 160 kDa):

  • Phosphorylated AS160 dissociates from intracellular storage vesicles carrying Glucose Transporter Type 4 (GLUT4).
  • GLUT4 vesicles translocate and fuse with the plasma membrane, driving rapid glucose uptake from the bloodstream via an insulin-independent pathway.
  • 4. Nuclear Retrograde Stress Translocation

    Under conditions of metabolic or oxidative stress (e.g., glucose deprivation, heat shock):

  • MOTS-c translocates from the cytoplasm into the cell nucleus within 30 minutes.
  • Inside the nucleus, MOTS-c physically interacts with chromatin at antioxidant response elements (ARE), cooperating with Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) to drive transcription of cytoprotective stress-response genes.
  • Key Study Highlights

    ✓

    Mitochondrial Genome Origin

    Endocrine peptide encoded within the mitochondrial 12S rRNA short open reading frame (sORF).

    ✓

    AMPK Phosphorylation

    Drives AMPK Thr172 phosphorylation via intracellular ZMP/AICAR accumulation.

    ✓

    Insulin-Independent GLUT4 Uptake

    Stimulates AS160 phosphorylation and GLUT4 plasma membrane translocation in myotubes.

    ✓

    Nuclear Retrograde Action

    Translocates to the nucleus under stress to co-activate NRF2 antioxidant gene networks.

    Scientific FAQs

    MOTS-c is encoded in a short open reading frame (sORF) within the 12S rRNA gene of mtDNA. It is exported to cytoplasmic ribosomes where it is translated into the bioactive 16-amino-acid peptide.
    MOTS-c activates the AMPK signaling pathway, stimulates GLUT4 glucose uptake in skeletal muscle, and increases fatty acid beta-oxidation, replicating the primary biochemical cascades triggered by endurance exercise.
    Molecular Formula: C101H152N28O22S2, Molecular Weight: 2174.62 g/mol, CAS Number: 1627580-64-6.
    Reconstitute with sterile Bacteriostatic Water (0.9% benzyl alcohol). Store lyophilized powder at -20°C protected from light. Reconstituted solutions should be refrigerated at 2-8°C and used within 28 days.

    References

    1. Lee C. et al (2015).
      The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces diet-induced obesity
      Cell Metab, 21(3):443-454
    2. Reynolds J.C. et al (2021).
      MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical capacity and systemic metabolism
      Nat Commun, 12(1):470

    Procure Research Reference Materials

    Access laboratory-grade reference compounds with verified batch HPLC purity reports and sterility documentation.

    View Compound Specifications

    Literature Inquiries

    Have questions about the pre-clinical citations or chemical parameters detailed in this research? Connect with our analytical representatives.

    Contact Researchers